This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Triglyceride Storage Disease With Ichthyosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Triglyceride Storage Disease With Ichthyosis shares some biological mechanisms with congenital-ichthyosis, congenital-nonbullous-ichthyosiform-erythroderma, exfoliative-dermatitis, fatty-liver, hepatomegaly, hereditary-diseases, ichthyoses, ichthyosiform-erythroderma-congenital, lipid-metabolism-disorders, lipoidosis, liver-cirrhosis, metabolic-diseases, myopathy, nervousness, steatohepatitis, steatosis, storage-disease, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Triglyceride Storage Disease With Ichthyosis, and have been seen in publications frequently: Cholesterol Esterification, Cornification, Fatty Acid Oxidation, Glycolysis, Keratinization, Keratinocyte Differentiation, Lipid Binding, Lipid Homeostasis, Lipid Oxidation, Lipid Storage, Lipid Transport, Localization, Mitochondrial Transport, Pathogenesis, Rna Interference, Secretion, Skin Development, Translation, Transport
Quite a number of genes have been found to play important roles in Triglyceride Storage Disease With Ichthyosis, such as ABHD5, CHKA, CHKB, CPT2, ETFA, ETFB, ETFDH, FKTN, FMN1, FOXC2, HSP90AA1, MADD, MBOAT2, PLIN1, PLIN2, PNPLA2, SLC22A5, TG, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.